Tetrapyrroles and derivatives
Frontier Specialty Chemicals 50MG 5-MONO(4-CARBOXYPHENYL)-1
5-mono(4-carboxyphenyl)-10,15,20-triphenyl porphyrin; CAS: 95051-10-8; 50mg
Frontier Specialty Chemicals 1G MESO-TETRA(4-CARBOXYPHENYL)
This item has a minimum qty of 2 per supplier requirements.
meso-Tetra(4-carboxyphenyl)porphine; CAS: 14609-54-2; 1g
Frontier Specialty Chemicals 250MG MESO-TETRA(4-CARBOXYPHEN
This item has a minimum qty of 3 per supplier requirements.
meso-Tetra(4-carboxyphenyl)porphine; CAS: 14609-54-2; 250mg
Frontier Specialty Chemicals 250MG MESO-TETRA(P-HYDROXYPHEN
This item has a minimum qty of 3 per supplier requirements.
meso-Tetra(p-hydroxyphenyl)porphine; CAS: 51094-17-8; 250mg
Frontier Specialty Chemicals 5G MESO-TETRAPHENYLPORPHINE (C
meso-Tetraphenylporphine (chlorin free); CAS: 917-23-7; 5g
Abcam Bisindolylmaleimide II, PKC inhibitor, 5MG
MW 438.5 Da, Purity >97%. Potent, selective ATP-competitive PKC inhibitor (IC₅₀ values are 0.01, 0.75 and 2 μM for PKC, phosphorylase kinase and PKA respectively). Potent noncompetitive nAChR antagonist (IC₅₀ = 0.03 μM, catecholamine secretion in nicotine-stimulated PC-12 cells). Shows more potent antinicotinic effects than Bisindolylmaleimide IV (ab144208) and V (ab144205). Induces apoptosis and shows antiproliferative effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Flupirtine maleate, Neuronal potassium channel opener, 25MG
MW 420.4 Da, Purity >99%. Neuronal potassium channel opener. Activates Kv7.2 channels and potently activates the inwardly rectifying potassium current (KIR; EC₅₀ = 600 nM). Centrally acting, non-opiate analgesic. Neuroprotective and antiapoptotic agent. Also has muscle relaxant properties. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Amylin (human), Endogenous peptide, 2500UG
MW 3903.3 Da, Purity >95%. Amylin (human), Endogenous peptide. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam QNZ, NF-kB inhibitor, 1MG
MW 358.4 Da, Purity >98%. Potent, selective NF-kB inhibitor (IC₅₀ = 11 nM). Inhibits LPS-induced TNFα production (IC₅₀ = 7 nM). Reduces edema in inflammation in vivo..
The product is subject to the following: Abcam Restricted Use Statement
Abcam (±)-Miconazole nitrate, Imidazole antifungal agent, 1G
MW 479.1 Da, Purity >99%. Imidazole antifungal agent. Inhibits fungal membrane ergosterol biosynthesis. Increases reactive oxygen species production.
The product is subject to the following: Abcam Restricted Use Statement
Abcam HTMT (Histamine trifluoromethyl toluidide) dimaleate, H1/H2 receptor agonist, 10MG
MW 628.6 Da, Purity >99%. H1/H2 receptor agonist (Ki = 1.2 µM). More potent than histamine (ab120734). Activates IP3/Ca2+ signaling and induces proliferation of small cholangiocytes. Active *in vivo*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam HTMT (Histamine trifluoromethyl toluidide) dimaleate, H1/H2 receptor agonist, 50MG
MW 628.6 Da, Purity >99%. H1/H2 receptor agonist (Ki = 1.2 µM). More potent than histamine (ab120734). Activates IP3/Ca2+ signaling and induces proliferation of small cholangiocytes. Active *in vivo*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Nafadotride, D3 antagonist, 50MG
MW 365.5 Da, Purity >99%. Potent, selective D3 antagonist (Ki values are 0.52 nM (D3), 269 nM (D4) and 5 nM (D2)).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Edaravone (MCI-186), antio x idant, 50MG
MW 174.2 Da, Purity >99%. Free radical scavenger and potent antioxidant. Inhibits production of reactive oxygen species, apoptosis and the lipoxygenase system.
The product is subject to the following: Abcam Restricted Use Statement